Tech Company Financing Transactions
Bridge Laboratories Funding Round
Bridge Laboratories, operating out of Irvine, scored $18 million from private investors.
Transaction Overview
Company Name
Announced On
1/15/2008
Transaction Type
Venture Equity
Amount
$18,000,000
Round
Series C
Investors
Proceeds Purpose
This new capital will enable Bridge Laboratories to execute their strategy of expanding their industry-leading toxicology lab in Beijing, China, and continue to grow their US operations. It will also provide the company with the flexibility to consider acquisitions that would enhance Bridge's facilities or capabilities.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
6 Venture 250
Irvine, CA 92618
USA
Irvine, CA 92618
USA
Phone
Website
Email Address
Overview
Bridge is a US-headquartered preclinical contract-research organization (CRO) focusing on providing US-regulatory compliant drug development services in the US and Asia. Currently Bridge operates the largest vivarium and US-level compliant pharmaceutical drug testing lab in China.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tom Oakley
Browse more venture capital transactions:
Prev: 1/15/2008: ProQuo venture capital transaction
Next: 1/15/2008: Centric Software venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on tech company VC transactions. VC investment data records reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs